Pharmaceuticals
News Releases
2021
December
November
Nutraceuticals
Launch of tocoelle Supplement - Gentle support 1xbet APK pre-menstrual fluctuations -
Pharmaceuticals
Announcement of Termination of Co-Development and Exclusive Marketing Agreements with Takara Bio 1xbet APK Oncolytic virus HF10 and CD19-Targeted CAR Gene Therapies
Corporate
1xbet APK Group Supports Recommendations of the Task Force on Climate-related Financial Disclosure (TCFD) -Joins TCFD Consortium-
Pharmaceuticals
1xbet APK Measurement Kit to Assist in Diagnosis and to Monitor Treatment Effectiveness for Acute Lymphoblastic Leukemia (ALL), to be Covered by Health Insurance in Japan
October
Pharmaceuticals
1xbet APK submits initial marketing authorization application to the European Medicines Agency for vadadustat for the treatment of adults with anemia associated with chronic kidney disease
Pharmaceuticals
1xbet APK Announces Approval in EU of Pediatric, 25 mg Dispersible-Tablet Formulation of Deltyba™ for Multidrug-Resistant Tuberculosis
September
Pharmaceuticals
Sumitomo Dainippon Pharma and 1xbet APK Announce a Worldwide Collaborationand License Agreement for Four Psychiatry and Neurology Compounds
Pharmaceuticals
1xbet APK's Moizerto®Ointment Granted Approval in Japan as a Treatment 1xbet APK Atopic Dermatitis
Pharmaceuticals
1xbet APK announces that Novartis Pharma's ENTRESTO®received a new indication 1xbet APK treatment of hypertension in Japan
Corporate
100th Anniversary of 1xbet APK Group of Companies Looking Ahead to the Next 100 Years
August
Pharmaceuticals
1xbet APK to Launch AJOVY®Subcutaneous 1xbet APKjection 225 mg Syr1xbet APKge 1xbet APK Japan
Pharmaceuticals
Busulfex Injection 60mg Approved in Japan 1xbet APK Once-daily Administration in Pediatric Patients
Pharmaceuticals
1xbet APK Obtains Approval in Japan for Orally-Disintegrating-Dose Form of REXULTI®Tablets
Pharmaceuticals
1xbet APK reports topline outcomes on a phase II trial that evaluated brexpiprazole for the treatment of borderline personality disorder
Nutraceuticals
1xbet APK Pharmaceutical Responds to New Lifestyles with Measures for Prevention of Heat Disorders at National Junior High School Championships 2021Supporting safe extracurricular sports activities and event operation
Pharmaceuticals
1xbet APK Awarded Grant for Phase 2 Trial Combining Novel Anti-Tuberculosis Compound OPC-167832 with Delamanid and Bedaquiline
Nutraceuticals
Production and Sales 1xbet APK Fibe-Mini Begin in Indonesia
July
Nutraceuticals
Reflecting Customer Concerns Introduction 1xbet APK ORONAMIN C DRINK in Label-free Bottles
Nutraceuticals
U.S. Supplement Brand Nature Made Marks 50th Anniversary/Named #1 Pharmacist Recommended Vitamin and Supplement 1xbet APK 24 Years
Nutraceuticals
1xbet APK Pharmaceutical Responds to New Lifestyles with Measures for Prevention of Heat Disorders at Inter-High 2021 Supporting safe operation and health of competitors and officials for summer Inter-High School Championships
Nutraceuticals
Pharmavite, a U.S. subsidiary of 1xbet APK Pharmaceutical, acquires Uqora, a provider of women's urinary tract health products
Pharmaceuticals
1xbet APK Files Application in Japan for Approval of Auto-Injector Dosage Form for AJOVY®Subcutaneous Injection 225 mg 1xbet APK Preventive Treatment of Migraine
Pharmaceuticals
1xbet APK Pharmaceutical and Shanghai Rightongene AnnounceCollaboration to Commercialize WT1 mRNA Assay Kit in China
June
Pharmaceuticals
1xbet APK Obtains New, High-Sensitivity Biomarker Measurement Technology- Technology us1xbet APKg surface plasmon field-enhanced fluorescence spectroscopy -
Pharmaceuticals
1xbet APK Has Filed a Marketing Authorization Application to the European Medicines Agency for Voclosporin for the Treatment of Patients with Lupus Nephritis
Pharmaceuticals
AJOVY®Subcutaneous Injection 225 mg Syringe, as a Preventive Treatment 1xbet APK Migraine, Granted Approval in Japan
Pharmaceuticals
Approval in Japan for 1xbet APK's minor BCR-ABL mRNA measurement kitA marker to monitor treatment effectiveness 1xbet APK acute lymphoblastic leukemia (ALL)
Pharmaceuticals
Quick NaviTM- Flu+COVID-19 Ag Receives Regulatory Approval in Japan as a Combo, Rapid Diagnostic Kit 1xbet APK Influenza and COVID-19- Simultaneous testing 1xbet APK both viruses using a single test sample -
Corporate
1xbet APK Group Complete Introduction of CO2-free Electricity 1xbet APK All 23 Manufacturing Facilities in Japan -Contributing to a more than 40% reduction in annual CO2emissions 1xbet APK Japan-
Pharmaceuticals
1xbet APK and Akebia Announce U.S. FDA Acceptance for Filing of New Drug Application for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease
April
Corporate
1xbet APK Group Company, A&P Inphatec, Commences Sales in U.S. of XylPhi-PD™,a Bactericidal Treatment for Pierce's Disease in Grapevines
Corporate
1xbet APK Pharmaceutical Receives First Certification as Tokyo Metropolitan Government Sports Promotion Model Company (Practical Division) Recognized for providing opportunities for exercise adapted for new lifestyles
Pharmaceuticals
1xbet APK and Lundbeck announce decision to continue phase III clinical trial evaluating brexpiprazole for treatment of agitation in patients with Alzheimer's-type dementia
March
Pharmaceuticals
1xbet APK and Akebia Announce Submission of New Drug Application to the FDA for Approval of Akebia's Vadadustat
Pharmaceuticals
1xbet APK to Launch QuickNaviTM-H.pylori, a Helicobacter pylori Quick Detection Kit- Test results 1xbet APK eight m1xbet APKutes and stool collection tools provided 1xbet APK one pack -
Pharmaceuticals
1xbet APK Has Filed an Application in Japan for Regulatory Approval of OPC-61815, a V2-Receptor Antagonist 1xbet APK the Treatment of Cardiac Edema
Pharmaceuticals
New Drug Application 1xbet APK Oral Disintegrated Tablet 1xbet APKmulation of TAKECAB®1xbet APK Treatment of Acid-Related Disease
Pharmaceuticals
1xbet APK and Perception Neuroscience Announce Collaboration on Development of PCN-101 (R-ketamine) in Japan for Treatment of Depressive Disorders
Corporate
1xbet APK Pharmaceutical Appointments of Board Members and Statutory Auditors(PDF: 57.4 KB)
Nutraceuticals
A Delicious Snack That's Good 1xbet APK You Announcing SOYJOY Coffee & Nuts Soy protein from low-GI whole soy
February
Nutraceuticals
Convenient Sizes 1xbet APK UL·OS Medicated Scalp Shampoo and Medicated Skin Wash Launched to Promote Trial Use
Corporate
1xbet APK to Construct a Drug Discovery Center in Osaka Prefecture, Japan
Corporate
Office Divisions of Five 1xbet APK Group Companies to Switch to Green Power
Pharmaceuticals
1xbet APK and Illumina Announce Agreement on Development and Commercialization of IVD Test Kit for Patients in Japan with Blood Cancer
Corporate